Table 1.
Distribution of Demographic and Tumor Characteristics of Interest and Multivariable-Adjusted Odds Ratios (ORs) and 95% CIs for Each Variable of Interest and COVID-19 Hospitalization Status Among 1,257,377 New York State Residents with a History of Cancer
| Variable | Cancer cases with COVID-19 hospitalization (n = 10,210), n (%) | Cancer cases without COVID-19 hospitalization (n = 1,247,167), n (%) | P value* | OR (95% CI)** | OR (95% CI)*** |
|---|---|---|---|---|---|
| Age in years, mean (SD) | 74.0 (12.9) | 68.2 (15.2) | <.0001 | ||
| Age group (y) | <.0001 | ||||
| 0-19 | 30 (0.3) | 8,340 (0.7) | 0.71 (0.49-1.04) | 0.71 (0.48-1.03) | |
| 20-29 | 38 (0.4) | 14,798 (1.2) | 0.63 (0.45-0.88) | 0.62 (0.44-0.88) | |
| 30-39 | 71 (0.7) | 35,372 (2.8) | 0.52 (0.40-0.68) | 0.52 (0.40-0.68) | |
| 40-49 | 267 (2.6) | 70,967 (5.7) | Ref | Ref | |
| 50-59 | 841 (8.2) | 174,431 (14.0) | 1.28 (1.12-1.47) | 1.27 (1.11-1.46) | |
| 60-69 | 2,041 (20.0) | 314,699 (25.2) | 1.73 (1.52-1.96) | 1.72 (1.51-1.95) | |
| 70-79 | 3,249 (31.8) | 348,433 (27.9) | 2.59 (2.28-2.93) | 2.58 (2.28-2.93) | |
| >80 | 3,673 (36.0) | 280,127 (22.5) | 4.00 (3.53-4.54) | 4.01 (3.54-4.55) | |
| Sex | <.0001 | ||||
| Male | 5,627 (55.1) | 572,339 (45.9) | 1.35 (1.29-1.40) | 1.34 (1.29-1.40) | |
| Female | 4,583 (44.9) | 674,828 (54.1) | Ref | Ref | |
| Race/ethnicity | <.0001 | ||||
| Non-Hispanic White | 6,276 (61.5) | 882,587 (70.8) | Ref | Ref | |
| Non-Hispanic Black | 1,930 (18.9) | 152,041 (12.2) | 1.75 (1.66-1.85) | 1.91 (1.81-2.01) | |
| Non-Hispanic Asian/Pacific Islander | 454 (4.4) | 66,127 (5.3) | 0.99 (0.89-1.09) | 1.09 (0.99-1.20) | |
| Hispanic | 1,457 (14.3) | 126,327 (10.1) | 1.66 (1.56-1.77) | 1.83 (1.73-1.94) | |
| Non-Hispanic other/unknown | 93 (0.9) | 20,085 (1.6) | 0.75 (0.61-0.93) | 0.80 (0.65-0.98) | |
| Region of residency at cancer diagnosis | <.0001 | ||||
| New York City | 4,655 (45.6) | 469,750 (37.7) | 1.21 (1.16-1.27) | NA | |
| Rest of New York State | 5,555 (54.4) | 777,417 (62.3) | Ref | Ref | |
| Stage of Cancer | <.0001 | ||||
| Local | 4,926 (48.2) | 626,01 1 (50.2) | Ref | Ref | |
| Regional | 1,628 (15.9) | 205,539 (16.5) | 1.09 (1.03-1.15) | 1.09 (1.03-1.15) | |
| Distant | 1,983 (19.4) | 141,262 (1 1.3) | 1.69 (1.61-1.79) | 1.67 (1.61-1.79) | |
| Unknown stage | 1,673 (16.4) | 274,355 (22.0) | 0.79 (0.75-0.84) | 0.80 (0.75-0.84) | |
| Multiple Tumors | <.0001 | ||||
| No | 8,512 (83.4) | 1,106,958 (88.8) | Ref | Ref | |
| Yes | 1,698 (16.6) | 140,209 (11.2) | 1.23 (1.16-1.30) | 1.23 (1.16-1.29) | |
| Time since cancer diagnosis | <.0001 | ||||
| 0-2 years (2019-2021) | 1,840 (18.0) | 174,494 (14.0) | 1.53 (1.44-1.62) | 1.51 (1.42-1.61) | |
| 3-5 years (2016-2019) | 2,285 (22.4) | 240,208 (19.3) | 1.42 (1.34-1.50) | 1.41 (1.33-1.49) | |
| 6-10 years (2012-2016) | 2,404 (23.5) | 284,264 (22.8) | 1.25 (1.19-1.32) | 1.25 (1.18-1 .32) | |
| >10 years (1976-201 1) | 3,681 (36.1) | 548,201 (44.0) | Ref | Ref | |
*
P-values from χ2 tests for categorical variables and student's t test for mean age.
**
Analyses mutually adjusted for all variables in the table.
***
Analyses mutually adjusted for all variables in the table with the exception of region of residence at cancer diagnosis.